References
- Kotzin BL. Mechanisms of autoimmunity. Clinical immunology principles and practice2nd ed., RR Rich, TA Fleisher, WT Shearer, BL Kotzin, HW Schroeder, Jr. Chapter 58, Mosby Publishers, St Louis 2001; 58.1–58.13
- Toubi E, Shoenfeld Y. The role of CD40–CD154 interactions in autoimmunity and the benefit of disrupting this pathway. Autoimmunity 2004; 37(6–7)457–464
- Carneiro-Sampaio M, Liphaus BL, Jesus AA, Silva CA, Oliveira JB, Kiss MH. Understanding SLE physiopathology in the light of primary immunodeficiencies. J Clin Immunol 2008; 28(Suppl 1)S34–S41
- Vakkalanka RK, Woo C, Kirou KA, Koshy M, Berger D, Crow MK. Elevated levels and functional capacity of sCD40L in SLE sera. Arthritis Rheum 1999; 42(5)871–881
- Kato K, Santana-Sahagún E, Rassenti LZ, Weisman MH, Tamura N, Kobayashi S, Hashimoto H, Kipps TJ. The sCD154 in SLE. J Clin Invest 1999; 104(7)947–955
- Ferro D, Pignatelli P, Loffredo L, Conti F, Valesini G, D'Angelo A, Violi F. sCD40L plasma levels in patients with SLE: Modulation by APL. Arthritis Rheum 2004; 50(5)1693–1694
- Goules A, Tzioufas AG, Manousakis MN, Kirou KA, Crow MK, Routsias JG. Elevated levels of sCD40L in serum of patients with systemic autoimmune diseases. J Autoimmun 2006; 26(3)165–171
- Komura K, Fujimoto M, Matsushita T, Yanaba K, Kodera M, Kawasuji A, Hasegawa M, Takehara K, Sato S. Increased serum sCD40L levels in patients with systemic sclerosis. J Rheumatol 2007; 34(2)353–358
- Garmendia JV, Zabaleta M, Blanca I, Bianco NE, De Sanctis JB. Total and biologically active serum-sCD40L in patients with chronic idiopathic urticaria. Allergy Asthma Proc 2004; 25(2)121–125
- Lara L, Rivera H, Pérez-P C, Blanca I, Bianco NE, De Sanctis JB. Low density lipoprotein receptor expression and function in human polymorphonuclear leukocytes. Clin Exp Immunol 1997; 107: 205–212
- Katsiari CG, Liossis SN, Dimopoulos AM, Charalambopoulo DV, Mavrikakis M, Sfikakis PP. CD40L overexpression on TC and Mo from patients with SLE is resistant to calcineurin inhibition. Lupus 2002; 11(6)370–378
- Schiffer L, Bethunaickan R, Ramanujam M, Huang W, Schiffer M, Tao H, Madaio MP, Bottinger EP, Davidson A. Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol 2008; 180(3)1938–1947